CTNNB1 and neoplasm: BRAF mutation was significantly associated with older age, female sex, proximal tumour location, low differentiation grade, mucinous tumour type, MSI and expression of cyclin D1, and inversely associated with beta-catenin overexpression, p53 positivity and p27 expression.